Predict your next investment

Venture Capital
emven.com

See what CB Insights has to offer

Investments

69

Portfolio Exits

13

Funds

2

About Excel Venture Management

Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond. The Excel investment portfolio is balanced across healthcare IT and services, diagnostics, and medical devices, plus life science platforms that address adjacent markets including energy, chemicals, defense and agriculture. The majority of the team's prior investments, which include some of the world's premier healthcare and life science companies, are thriving and over half have achieved successful exits generating billions in value.

Excel Venture Management Headquarters Location

800 Boylston Street Suite 2825

Boston, Massachusetts, 02199,

United States

617-450-9800

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Excel Venture Management News

Neosensory : Announces $10 Million Series A Financing Round

Jan 9, 2019

0 Message : *Required fields PALO ALTO, Calif., Jan. 9, 2019 /PRNewswire/ --  Neosensory , a company that pioneers devices to send information to the brain non-invasively, today announced it has received $10 million of Series A financing. Excel Venture Management and DigiTx Partners co-led the round, with participation from existing investors True Ventures, Tao Capital, and several angel investors. With total funding of $16 million since launch, Neosensory plans to release their first product -- a wristband called the Buzz -- later this year. Excel's Juan Enriquez and DigiTx's David Kim will join Neosensory's Board of Directors. Co-founded by neuroscientists David Eagleman and Scott Novich, Neosensory develops consumer-friendly, non-invasive technology that was first introduced in a TED talk entitled Can we create new senses for humans? Their patented devices transform data streams into patterns of touch. One application relays sounds normally captured by the ear into vibrations on the skin, overcoming the cost and limitations of hearing aids and cochlear implants. Versions of Neosensory's technology were recently featured on National Geographic and in Season 2 of HBO's Westworld. "Neosensory's technology has the potential to extend our natural biological limitations," said Juan Enriquez, Managing Director at Excel Venture Management. "In the context of hearing loss, we believe the market is going to incorporate wearable devices such as Neosensory's wristband." Dr. David Kim, Managing Director of DigiTx Partners, added, "Dr. Eagleman and the Neosensory team are pushing the envelope in the field of sensory substitution. We are excited to support the transformation of the company from cutting-edge R&D to a strong commercial company serving the needs of millions of people." "We're just scratching the surface of how powerful sensory substitution can be when combined with well-designed wearables," said Eagleman, Neosensory's Chief Executive Officer. "The support and expertise of our investors will help us execute our vision rapidly and worldwide." About Neosensory Based in Palo Alto, California, Neosensory is a neuroscience-based company that expands perception. Neosensory's wearable device takes in information (for example, sound, light, or data streams from the net) and translates it into patterns of vibrations on the skin. With practice, associations become automatic and a new sense is born. Learn more at neosensory.com . About Excel Venture Management Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond. Their investment portfolio spans healthcare IT and services, diagnostics, medical devices, and life science platforms. Companies funded by Excel include ShapeUp, Openwater, and ClearData. Learn more at excelvm.com . About DigiTx Ventures DigiTx Partners supports founders who strive to keep all people in better health. They fund companies that create innovative solutions across healthcare and life sciences, targeting data-driven technologies that generate competitive insights and improve patient outcomes. Companies funded by DigiTx include Eko Devices, Welldoc, and Tissue Analytics. Learn more at digitxpartners.com . SOURCE Neosensory

Excel Venture Management Investments

69 Investments

Excel Venture Management has made 69 investments. Their latest investment was in Ayogo as part of their Series B on May 5, 2020.

CBI Logo

Excel Venture Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/1/2020

Series B

Ayogo

$5.31M

No

1

1/4/2019

Series A

NeoSensory

$10M

Yes

4

9/27/2018

Series E

ClearDATA

$26M

No

6

8/14/2018

Series C

Subscribe to see more

$99M

Subscribe to see more

10

5/9/2018

Seed VC

Subscribe to see more

Subscribe to see more

10

Date

5/1/2020

1/4/2019

9/27/2018

8/14/2018

5/9/2018

Round

Series B

Series A

Series E

Series C

Seed VC

Company

Ayogo

NeoSensory

ClearDATA

Subscribe to see more

Subscribe to see more

Amount

$5.31M

$10M

$26M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

4

6

10

10

Excel Venture Management Portfolio Exits

13 Portfolio Exits

Excel Venture Management has 13 portfolio exits. Their latest portfolio exit was IlluminOss Medical on May 01, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/1/2020

Acq - Fin

$99M

5

1/7/2019

Acquired

$99M

3

10/18/2017

Acquired

$99M

3

6/29/2017

IPO

Subscribe to see more

$99M

Subscribe to see more

10

3/17/2017

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/1/2020

1/7/2019

10/18/2017

6/29/2017

3/17/2017

Exit

Acq - Fin

Acquired

Acquired

IPO

Reverse Merger

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

5

3

3

10

10

Excel Venture Management Fund History

2 Fund Histories

Excel Venture Management has 2 funds, including Excel Medical Fund LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/30/2009

Excel Medical Fund LP

Multi-Stage Venture Capital

Closed

$125M

1

Excel Venture Fund II LP

Subscribe to see more

Subscribe to see more

10

Closing Date

6/30/2009

Fund

Excel Medical Fund LP

Excel Venture Fund II LP

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$125M

Sources

1

10

Excel Venture Management Team

5 Team Members

Excel Venture Management has 5 team members, including current Chief Financial Officer, Jeanne L Henry.

Name

Work History

Title

Status

Enrico Petrillo

CB Health Ventures, and Fletcher Spaght

Founder

Current

Jeanne L Henry

Atlas Venture

Chief Financial Officer

Current

Juan Enriquez

Managing Director

Current

Steve Gullans

Managing Director

Current

Caleb Winder

Managing Director

Current

Name

Enrico Petrillo

Jeanne L Henry

Juan Enriquez

Steve Gullans

Caleb Winder

Work History

CB Health Ventures, and Fletcher Spaght

Atlas Venture

Title

Founder

Chief Financial Officer

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.